NBP258282PE

Novus Biologicals™ EDEM3 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP258282PE-Each-of-1 In Stock ₹ 31,372.50

NBP258282PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

80267

Common Name

EDEM3 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

C1orf22, chromosome 1 open reading frame 22, ER degradation enhancer, mannosidase alpha-like 3, ER degradation-enhancing alpha-mannosidase-like 3, ER degradation-enhancing -mannosidase-like protein 3

Label Type

Unlabeled

Quantity

100μL

Source

E.Coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

EDEM3

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51132. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP258348PE

--

Img

Novus Biologicals™

NBP258255PE

--

Img

Novus Biologicals™

NBP258856PE

--

Img

Novus Biologicals™

NBP258670PE

--

Img

Novus Biologicals™

NBP258815PE

--

Img

Novus Biologicals™

NBP258243PE

--

Img

Novus Biologicals™

NBP258631PE

--

Img

Novus Biologicals™

NBP258266PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human EDEM3
  • Source: E.coli Amino Acid Sequence: SSQEVDLVDQESSEENSLNSHPESLSLADMDNAASISPSEQTSNPTENHETTNLNGECTDLDNQLQEQSETEEDSNPNVSWGKKVQPIDSILADWNEDIEAFEMMEKDE The EDEM3 Recombinant Protein Antigen is derived from E
  • coli
  • The EDEM3 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.